Oral contraceptives and benign breast disease: an update of findings in a large cohort study

Contraception

Volumn 76, Issue 6, 2007, Pages 418-424

  Vessey, Martin ^a   Yeates, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Benign breast disease; Chronic cystic disease; Cohort study; Fibroadenoma; Oral contraceptives

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; BREAST FIBROADENOMA; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; FIBROCYSTIC BREAST DISEASE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; ORAL CONTRACEPTION;

ADULT; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; RISK; RISK FACTORS;

EID: 36549001323     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.08.011     Document Type: Article

References (13)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347 (1996) 1713-1727
2. McGonigle K.F., and Huggins G.R. Oral contraceptives and breast disease. Fertil Steril 56 (1991) 799-819
3. Goehring C., and Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19 (1997) 310-327
4. Burkman R., Schlesselman J.J., and Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 190 (2004) S5-S22
5. The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reproduc Update 11 (2005) 513-525
6. Brinton L.A., Vessey M.P., Flavel R., and Yeates D. Risk factors for benign breast disease. Am J Epidemiol 113 (1981) 203-214
7. Vessey M., Doll R., Peto R., Johnson B., and Wiggins P. A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 8 (1976) 373-3427
8. Vessey M., Painter R., and Yeates D. Mortality in relation to oral contraception and cigarette smoking. Lancet 362 (2003) 185-191
9. Vessey M., and Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 95 (2006) 385-389
10. Breslow N.E., and Day N.E. Statistical methods in cancer research. The design and analysis of cohort studies vol. II (1987), International Agency for Research on Cancer, Lyon
11. Vessey M. 30th anniversary of the Oxford-FPA contraceptive study. Trends Urol Gynaecol Sex Health 3 (1998) 26-33
12. Janerich D.T., Glebatis D.M., and Dugan J.M. Benign breast disease and oral contraceptive use. JAMA 237 (1977) 2199-2201
13. Rohan T.E., and Miller A.B. A cohort study of oral contraceptive use and risk of benign breast disease. Int J Cancer 82 (1999) 191-196